These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Prevention of autoimmune gastritis in mice requires extra-thymic T-cell deletion and suppression by regulatory T cells. Read S; Hogan TV; Zwar TD; Gleeson PA; Van Driel IR Gastroenterology; 2007 Aug; 133(2):547-58. PubMed ID: 17603058 [TBL] [Abstract][Full Text] [Related]
25. The autoimmune diseases manifested by production of autoantibodies: the autoantigens identified by random peptide library. Jadali Z; Sanati MH Iran J Allergy Asthma Immunol; 2008 Sep; 7(3):115-31. PubMed ID: 18780947 [TBL] [Abstract][Full Text] [Related]
26. Autoantibodies in normals--the value of predicting rheumatoid arthritis. Dörner T; Hansen A Arthritis Res Ther; 2004; 6(6):282-4. PubMed ID: 15535841 [No Abstract] [Full Text] [Related]
27. MIF in autoimmunity and novel therapeutic approaches. Stosic-Grujicic S; Stojanovic I; Nicoletti F Autoimmun Rev; 2009 Jan; 8(3):244-9. PubMed ID: 18721909 [TBL] [Abstract][Full Text] [Related]
28. Clinical correlation of antimitochondrial antibodies. Zuber MA; Recktenwald C Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283 [TBL] [Abstract][Full Text] [Related]
29. Type 1 diabetes: lessons for other autoimmune diseases? Harrison LC; Honeyman MC; Morahan G; Wentworth JM; Elkassaby S; Colman PG; Fourlanos S J Autoimmun; 2008 Nov; 31(3):306-10. PubMed ID: 18558477 [TBL] [Abstract][Full Text] [Related]
31. Antigen-specific therapies for the treatment of autoimmune diseases. Hafler DA; Weiner HL Springer Semin Immunopathol; 1995; 17(1):61-76. PubMed ID: 7482227 [No Abstract] [Full Text] [Related]
32. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Binstadt BA; Patel PR; Alencar H; Nigrovic PA; Lee DM; Mahmood U; Weissleder R; Mathis D; Benoist C Nat Immunol; 2006 Mar; 7(3):284-92. PubMed ID: 16444258 [TBL] [Abstract][Full Text] [Related]
33. Cellular therapies in endocrine diseases. Papewalis C; Jacobs B; Wuttke M; Schott M Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S33-9. PubMed ID: 18777451 [TBL] [Abstract][Full Text] [Related]
34. Treating autoimmune diseases through restoration of antigen-specific immune tolerance. Wolfraim LA Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252 [TBL] [Abstract][Full Text] [Related]
35. Autoantigens act as tissue-specific chemoattractants. Oppenheim JJ; Dong HF; Plotz P; Caspi RR; Dykstra M; Pierce S; Martin R; Carlos C; Finn O; Koul O; Howard OM J Leukoc Biol; 2005 Jun; 77(6):854-61. PubMed ID: 15917448 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of autologous serum skin test in autoimmune urticaria. Husz S; Mihalyi L; Kemeny L J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1023-4. PubMed ID: 18513338 [No Abstract] [Full Text] [Related]
37. Prediction and prevention of autoimmune disease: a personal perspective. Rose NR Ann N Y Acad Sci; 2007 Aug; 1109():117-28. PubMed ID: 17785297 [TBL] [Abstract][Full Text] [Related]
38. Modulation of the immune system by dying cells and the phosphatidylserine-ligand annexin A5. Gaipl US; Munoz LE; Rödel F; Pausch F; Frey B; Brachvogel B; von der Mark K; Pöschl E Autoimmunity; 2007 Jun; 40(4):254-9. PubMed ID: 17516206 [TBL] [Abstract][Full Text] [Related]
39. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases. Ardesjö B; Hansson CM; Bruder CE; Rorsman F; Betterle C; Dumanski JP; Kämpe O; Ekwall O J Autoimmun; 2008 Jun; 30(4):273-82. PubMed ID: 18242955 [TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphisms as a prerequisite for autoantigens. Stadler MB; Arnold D; Frieden S; Luginbühl S; Stadler BM Eur J Immunol; 2005 Feb; 35(2):371-8. PubMed ID: 15627977 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]